The USAID Global Health Broad Agency Announcement for Research and Development (2018)
ID: 305999Type: Posted
Overview

Buyer

Agency for International Development (USAID)

Award Range

$0 - $0

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/305999
Timeline
    Description

    The Agency for International Development (USAID) has issued the Global Health Broad Agency Announcement (BAA) for Research and Development (2018), inviting organizations to collaborate in creating innovative health solutions aimed at addressing critical health issues in developing countries. The BAA seeks to harness science, technology, and innovation to co-create, co-design, and co-invest in effective interventions that target maternal and child health and combat preventable diseases such as HIV/AIDS and malaria. This initiative is crucial for reducing health disparities and improving health outcomes in regions where access to healthcare is limited. Interested parties can monitor Grants.gov and FedBizOpps for future Addenda detailing specific funding opportunities, with the BAA effective until May 30, 2022. For inquiries, contact the Global Health BAA team at GH-BAA-2018@usaid.gov.

    Point(s) of Contact
    GH-BAA-2018@usaid.gov
    Files
    Title
    Posted
    GH BAA 2018 - Announcement_060718_FINAL.pdf
    GH.pdf
    The USAID Global Health Broad Agency Announcement (BAA) for Research and Development (2018) invites collaboration in creating innovative health solutions to address critical issues in developing countries. This BAA outlines a two-step process: the initial announcement and subsequent Addenda that detail funding opportunities. The goal is to engage various organizations in co-creating effective interventions addressing maternal and child health and combating preventable diseases like HIV/AIDS and malaria. Key elements include a framework for co-creation, co-design, and co-investment among partners. The document emphasizes the need for high-impact projects and stresses that proposals must demonstrate significant contributions toward global health improvements. Awards are granted based on criteria such as reputation, technical ability, and the project’s potential for scalability and sustainability. The BAA, effective until May 30, 2022, stipulates insights on eligibility, collaboration rights, award types (including grants and contracts), and the necessity of protecting intellectual property during proposal evaluation. This initiative reflects USAID's commitment to leveraging scientific advancements to diminish health disparities in developing nations rapidly.
    Similar Opportunities
    The USAID Global Health Development Innovation Accelerator Broad Agency Announcement
    Active
    Agency for International Development
    The Agency for International Development (USAID) is inviting organizations to participate in the Global Health Development Innovation Accelerator Broad Agency Announcement (BAA), aimed at co-creating and scaling innovative solutions to address critical global health challenges. This initiative encourages a diverse range of eligible applicants, including public and private organizations, non-profits, and institutions of higher education, to submit proposals that demonstrate strong potential impacts on reducing maternal and neonatal mortality, particularly in low- and middle-income countries. The program emphasizes flexibility in partnerships and allows for multiple submissions from applicants, with funding amounts ranging from $250,000 to $2 million, and the application process is strictly time-bound with no extensions available. Interested parties should refer to individual addenda for specific contact information and submission deadlines, as the response dates are established by those addenda.
    INNOVATIVE HEALTH PRACTICES
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is forecasting a grant opportunity titled "Innovative Health Practices" aimed at co-creating and scaling innovative research and development interventions to reduce disease and mortality rates globally. This Broad Agency Announcement (BAA) invites unrestricted organizations and companies to submit Expressions of Interest (EOI) to collaborate on generating novel tools and approaches that enhance health outcomes in low-and-middle-income countries (LMICs). The initiative emphasizes the importance of local partnerships and innovative practices in global health, seeking to leverage diverse expertise and resources to address health challenges effectively. Interested applicants can reach out to Sharon D. Davis at shdavis@usaid.gov or call 202-567-4755 for further information, with applications expected to follow an addendum to this announcement, which is anticipated to close in fiscal year 2024.
    The USAID Fighting Ebola BAA
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is seeking innovative solutions through its Broad Agency Announcement (BAA) titled "The USAID Fighting Ebola BAA," aimed at combating the Ebola epidemic. This initiative invites public, private, for-profit, and non-profit organizations, as well as institutions of higher education and international organizations, to co-create and collaborate on practical innovations that enhance healthcare delivery and control the spread of Ebola. The program emphasizes the importance of developing cost-effective technologies to support healthcare workers on the front lines. Interested applicants must submit their expressions of interest by December 1, 2014, at 11:59 PM for consideration in the second round review, and can reach out to USAID at SubmitEbolaEOI@usaid.gov for further inquiries.
    Microbicides Research, Development, and Introduction
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    Frontier Health Markets APS
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting submissions for the Frontier Health Markets (FHM) Annual Program Statement (APS), aimed at enhancing global health outcomes related to maternal and child health, HIV/AIDS, and infectious diseases. This cooperative agreement seeks to engage both U.S. and non-U.S. organizations, including public, private, for-profit, and nonprofit entities, as well as institutions of higher education and international organizations, to submit concept papers for potential funding under various rounds of the APS. The initiative is critical for improving local health markets and fostering private sector involvement in health initiatives. Interested applicants can reach out to Jacquelin Bell at jacbell@usaid.gov for further information, with the closing date for submissions set for February 24, 2028.
    HIV/AIDS Activities
    Active
    Burundi USAID-Bujumbura
    The United States Agency for International Development (USAID) in Burundi is seeking innovative ideas and strategies to enhance its HIV/AIDS programming through a Request for Information (RFI) issued on March 17, 2022. The primary objective of this RFI is to gather insights on addressing gaps and challenges in the HIV response in Burundi, particularly focusing on clinical programming, community involvement, treatment interruptions, and the needs of orphans and vulnerable children. This initiative is crucial for improving the effectiveness and equity of HIV services in alignment with global health initiatives, emphasizing the importance of community participation in achieving epidemic control. Interested parties can submit their responses electronically by March 31, 2022, to Liliane Gatunange at lgatunange@usaid.gov, with no individual feedback provided to respondents.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is seeking expert input through a Request for Information (RFI) aimed at accelerating HIV vaccine research and development in low- and middle-income countries (LMICs). This initiative is designed to gather recommendations on opportunities, challenges, and gaps in HIV vaccine R&D, particularly focusing on collaborative ecosystems, efficient manufacturing, and community engagement. The RFI underscores USAID's commitment to enhancing partnerships and locally-led development in regions significantly impacted by HIV, including outreach to historically black colleges and universities (HBCUs) and minority-serving institutions (MSIs). Interested parties must submit their responses electronically by May 24, 2024, at 5:00 PM EDT, adhering to specific formatting guidelines, and can direct inquiries to Simone Cho at scho@usaid.gov.
    UNIVERSAL HEALTH CARE PROJECT APS
    Active
    Philippines USAID-Manila
    The U.S. Agency for International Development (USAID) Mission in the Philippines is inviting applications for the Universal Health Care Project (UHCP) Annual Program Statement (APS), aimed at enhancing health outcomes for underserved and vulnerable populations in the Philippines. The project focuses on strengthening health systems and improving service delivery in key areas such as tuberculosis (TB), HIV/AIDS, family planning, and global health security, aligning with both U.S. and Philippine health objectives. This initiative is critical for addressing systemic health challenges exacerbated by the COVID-19 pandemic and aims to foster collaboration among local and international organizations to build a more resilient health system. Interested applicants can submit concept papers until July 31, 2025, with an expected six awards to be made, and should direct inquiries to Howard Weston at manila-roaa-rfa@usaid.gov.
    USAID/Philippines Integrated Health Project
    Active
    Philippines USAID-Manila
    The United States Agency for International Development (USAID) Mission in Manila, Philippines, is forecasting an opportunity for the USAID/Philippines Integrated Health Project, aimed at enhancing health development assistance in the country. This initiative seeks to identify local organizations capable of addressing five Key Health Elements (KHE): Health Systems Strengthening, Family Planning and Adolescent Reproductive Health, Tuberculosis, HIV/AIDS, and Global Health Security. The project is particularly focused on engaging local entities that are majority-owned and managed by Philippine citizens or residents, as USAID aims to build partnerships to improve health outcomes amidst significant challenges exacerbated by global crises and the COVID-19 pandemic. Interested organizations are encouraged to respond to the Sources Sought Notice by providing details on their capabilities and past performance, with responses treated as informational only. For further inquiries, organizations may contact Gracelda M Laspinas at glaspinas@usaid.gov or by phone at 6323014929.